Brief introduction of the author of "Guide to the Research of New Anticancer Drugs"

Chen Qingqi, male, Lunar New Year 1963, from Anren County, Hunan Province. 1979 was admitted to Chenzhou Teachers College and graduated from 1982. In the same year, he was assigned to his hometown Anren County as a middle school teacher for three years. 1985 was admitted to the postgraduate class of organic chemistry in the Department of Chemistry of Yanbian University. 1987 graduate, assistant engineer of food additives in Beijing Food Industry Research Institute. 1990 was admitted to the chemistry department of Peking University. 1993 received a doctor of science degree (tutor: Jin Sheng, Ma Jinshi), and his research direction is fine chemical synthesis. During1993–1999, I worked at the University of Johannes-Kepler Linz (tutor: Dr. Heinz Falk) and the University of Nevada-Reno (tutor: Dr. David leitner). British Columbia University (tutor: Dr. David Dolphin) and other universities in Canada are engaged in natural products, drug synthesis and new drug research and development. Since 2000, he has entered the field of biotechnology and biopharmaceuticals, and has been engaged in research and development of new drugs, drug synthesis, drug formulation, development of new drug delivery technology, and research and management of drugs and drug rapid detection technology in many biotechnology and biopharmaceuticals high-tech companies in the United States and Canada. At present, a biopharmaceutical company in North Carolina, USA, is responsible for the research and development of new drugs and the chemical synthesis of raw materials and pharmaceutical intermediates. In addition, Chen Qingqi is currently a visiting professor at South China Normal University.

Chen Qingqi's main achievement: Of the new drugs that I directly participated in some research work, three have been approved for listing by the US FDA and more than 80 countries around the world. In addition, several new molecular solid drugs designed and developed by myself have entered the pre-clinical or clinical trial stage. As of July 2008, nearly 90 scientific papers and many invention patents have been published in internationally renowned scientific journals. In 2000, he was selected into the "Hundred Talents Program" of China Academy of Sciences. The main scientific research works are: Handbook of the Manufacture and Chemical Synthesis of Small Molecule Drugs (published by Hunan Science and Technology Press in April 2008); American Patent Drug Research Guide (Science Press, May 2008); Handbook of Total Synthesis Route of New Drug Chemistry (edited by Chen Qingqi, edited by Chen Bingzi, Chen Qingqi, Tu Bin, Xiao, Xue Song and Zhang Yi, Science Press, published in July 2008); A quick survey of the total synthetic route of anticancer drugs (published by Science Press at the end of 2008); Guide to the research of new anticancer drugs (Science Press, published in 2009).